Abstract
Uptake of 18F-NaF is not tumor specific, and nonmalignant entities can demonstrate radiotracer uptake, including arthritis, trauma, and bone processes such as fibrous dysplasia and Paget disease. The degree of radiotracer uptake cannot be used to differentiate benign from malignant lesions. Many benign bone lesions, including osteophytes and degenerative endplate changes, will show increased 18F-NaF uptake [1].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Reference
Segall G, et al. SNM practice guideline for sodium 18F-Fluride PET/CT bone scan 1.0. J Nucl Med. 2010;51(11):1813–20.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Xu, G. (2020). 18F-Fluoride Imaging: Atlas of Interesting Images (Images with Specific Teaching Points, Tracer, Technique, and Pitfalls). In: Kairemo, K., Macapinlac, H.A. (eds) Sodium Fluoride PET/CT in Clinical Use. Clinicians’ Guides to Radionuclide Hybrid Imaging(). Springer, Cham. https://doi.org/10.1007/978-3-030-23577-2_8
Download citation
DOI: https://doi.org/10.1007/978-3-030-23577-2_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-23576-5
Online ISBN: 978-3-030-23577-2
eBook Packages: MedicineMedicine (R0)